VACCINES
LICENSED IN THE UNITED STATES AND THEIR ROUTES OF ADMINISTRATION
|
VACCINE
*
|
TYPE
|
ROUTE
|
|
Adenovirus‡
|
Live
Virus |
Oral |
|
Anthrax§
|
Inactivated
Virus |
Subcutaneous |
|
BCG
|
Live
Bacteria |
Subcutaneous,
Intramuscular, & Intradermal |
|
Cholera
|
Inactivated
Virus |
Intradermal
(preferred), or Subcutaneous |
|
Ditptheria-tetanus
(dT, DT)
|
Toxoids |
Intramuscular |
|
DTP
|
Toxoids
and inactivated bacteria |
Intramuscular |
|
DTaP
|
Toxoids
and inactivated bacterial components |
Intramuscular |
|
Hepatitis
A
|
Inactivated
viral antigen
|
Intramuscular |
|
Hepatitis
B
|
Inactivated
viral antigen |
Intramuscular |
|
Hib
Conjugates¶
|
Polysaccharide-protien
conjugate |
Intramuscular |
|
Hib
Conjugates - DTP (HbOC¶
- DTP and PRP-T¶ reconstituted
with DTP)
|
Polysaccharide-protien
conjugate with toxoids and inactivated bacteria |
IIntramuscular |
|
Hib
Conjugates - DTaP (PRP-T¶ reconstituted
with DTaP)
|
Polysaccharide-protien
conjugate with toxoids and inactivated bacterial components
|
Intramuscular |
|
Hib
Conjugate (PRP-OMP¶)
- hepatitis B
|
Polysaccharide-protien
conjugate with inactivated bacteria
|
Intramuscular |
|
Influenza
|
Inactivated
Virus (whole virus), viral components |
Intramuscular |
|
Japanese
encephalitis
|
Inactivated
Virus |
Subcutaneous |
|
Lyme
Disease
|
Inactivated
Protein |
Intramuscular |
|
Measels
|
Live
Virus |
Subcutaneous |
|
Meningococcal
|
Polysaccharide |
Subcutaneous |
|
MMR
|
Live
Viruses |
Subcutaneous |
|
Measels-rubella
|
Live
Viruses |
Subcutaneous |
|
Mumps
|
Live
Virus |
Subcutaneous |
|
Pertussis§
|
Inactivated Bacteria |
Intramuscular |
|
Plague
|
Inactivated
Bacteria |
Intramuscular |
|
Pneumococcal
|
Polysaccharide |
Intramuscular
or Subcutaneous |
|
Poliovirus
IPV
OPV
|
Inactivated Virus
Live Virus |
Subcutaneous
Oral |
|
Rabies
|
Inactivated
Virus |
Intramuscular
or
Intradermal±
|
|
Rubella
|
Live
Virus |
Subcutaneous |
|
Tetanus
|
Toxoid |
Intradermal |
|
Typhoid
Parenteral
Parenteral
Oral
|
Inactivated Bacteria
Capsular Polysaccharide
Live Bacteria |
Subcutaneous
Subcutaneous (boosters may be Intradermal)
Oral |
|
Varicella
|
Live
Virus |
Subcutaneous |
|
Yellow
Fever
|
Live
Virus |
Subcutaneous |
* BCG
indicates bacillus Calmette-Guerin; DTP, diptheria
and tetanus toxoids and pertussis,
absorbed; DTaP, diptheria
and tetanus toxoids and acellular
pertussis, absorbed; Hib,
Haemophilus influenzae
type b; MMR, live measels-mumps-rubella
viruses; OPV, oral poliovirus;
IPV, inactivated poliovirus;
dT,diptheria and
tetanus toxoids (for children 7 years of age or older
and adults0; DT, diptheria
and tetanus toxoids (for
children younger than 7 years of age).
‡
Available only to US Armed Forces. No longer being manufactured;
existing supplies continue to be used.
§
Disrtibuted
by Bio Port Corporation, Lansing MI.
¶
HbOC (diptheria CRM197 protein conjugate),
PRP-OMP,(polyribosylribotol phosphate-outer membrane protein),
and PRP-T are recommended for infants beginning at approxiamtely
2 months of age.
±
Human diploid cell rabies vaccinefor
intradeermal use is different in constituion and potency from
the intramuscular vaccine; it should be used for preexposure
immunization only. Rabies vaccine absorbed and RabAvert should
not be given intradermally.
Back
